Poland· PL-100519478
Ispazin forte
A alverine product containing alverini citras, registered in Poland by Solinea Sp. z o.o.. The same ATC class is registered in 4 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Alverine is registered in 4 of 19 countries.
Countries holding a registration under ATC A03AX08 (alverine), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 2 of them publish a price we can compare per daily dose
Alverine · ATC A03AX08
4 / 19 countries
- Belgiumprice
- Ireland
- Polandprice
- United Kingdom
The record
At a glance
URPL (Poland)- Active substance
- Alverini citras
- Manufacturer
- Solinea Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- A03AX08
- ATC class
- Alverine
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 3
- gtin05907572581348
- gtin05907572581324
- gtin05907572581331
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Alverine in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomAlverine 120mg capsulesZentiva Pharma UK Ltd
- BelgiumSpasmine Forte 120 mgCooper Consumer Health
- CzechiaSIMVEROLZaklady Farmaceutyczne Polpharma SA, Starogard Gdański
- IrelandSpasmonal 60mg hard CapsulesViatris Healthcare Limited
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- Belgium · Spasmine, Spasmine Forte
- United Kingdom (Northern Ireland) · Alverine Citrate, Alverine Citrate Blackrock Pharmaceuticals
- Ireland · Spasmonal
- Luxembourg · Spasmine, Spasmine Forte
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d15c7b53-ad21-45a5-a745-ce9951be157d GET /v1/drugs/d15c7b53-ad21-45a5-a745-ce9951be157d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Kapsułki twarde",
"source": "urpl",
"strength": "120 mg",
"packaging": "05907572581324 ¦ Rp ¦ 166466\n10 kaps.\n05907572581331 ¦ Rp ¦ 166467\n20 kaps.\n05907572581348 ¦ Rp ¦ 166468\n30 kaps.",
"substance": "Alverini citras 120 mg",
"common_name": "Alverini citras",
"pl_product_id": "100519478",
"pozwolenie_nr": "29757",
"auth_procedure": "NAR",
"authorisation_validity": "2031-06-10"
}See everything about alverine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.